risedronic acid has been researched along with malondialdehyde in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadillioglu, E; Kaya, H; Ozgocmen, S; Yilmaz, Z | 1 |
1 trial(s) available for risedronic acid and malondialdehyde
| Article | Year |
|---|---|
Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis.
Topics: Adult; Aged; Antioxidants; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcitonin; Erythrocytes; Etidronic Acid; Female; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Nitric Oxide; Osteoporosis, Postmenopausal; Oxidative Stress; Oxidoreductases; Raloxifene Hydrochloride; Risedronic Acid | 2007 |